3rd Quarter - Report — INFECTIOUS DISEASES SOCIETY OF AMERICA for INFECTIOUS DISEASES SOCIETY OF AMERICA (2012)

Firm

INFECTIOUS DISEASES SOCIETY OF AMERICA

Client

INFECTIOUS DISEASES SOCIETY OF AMERICA

Income

—

Expenses

$87,401

Expense method

C: businesses, Internal Revenue Code section 162(e)

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Funding support for the Department of Health and Human Services, Office of the Biomedical Advanced Research and Development Authority, Centers for Disease Control and Prevention, National Institutes of Health, Health Resources & Services Administration, Food & Drug Administration and global programs for various infectious diseases related issues.

Lobbyist	Covered position, as disclosed
ROBERT J GUIDOS	V.P. Public Policy & Government Relations
AMANDA JEZEK	Government Relations Director
KIMBERLY ANN MILLER	HIV Medicine Association Policy Officer

Contacted: Natl Institutes of Health (NIH); Health Resources & Services Administration (HRSA); U.S. Agency for International Development (USAID); SENATE; Health & Human Services, Dept of (HHS); Agency for Healthcare Research & Quality (AHRQ); Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Medical/Disease Research/Clinical Labs MED

Medical liability; antimicrobial resistance research; infectious diseases product research and development; regulatory science; unnecessary regulatory burdens placed on medical research; laboratory developed tests; comparative effectiveness research; support for evidence-based decision making; point-of-care diagnostic tests; and organ transplant policy to allow HIV+ to HIV+ organ transplants

Lobbyist	Covered position, as disclosed
ROBERT J GUIDOS	V.P. Public Policy & Government Relations
AMANDA JEZEK	Government Relations Director
KIMBERLY ANN MILLER	HIV Medicine Association Policy Officer

Contacted: SENATE; Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Agency for Healthcare Research & Quality (AHRQ); Centers For Disease Control & Prevention (CDC); U.S. Agency for International Development (USAID); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Health Issues HCR

Infectious diseases; drug, diagnostics and vaccine research and development; antimicrobial resistance; antimicrobial stewardship; hospital-acquired infections; immunizations; pandemic influenza, public health security and biodefense; global infectious diseases; biomedical research, reauthorization of President's Emergency Plan for AIDS Relief (PEPFAR); Lyme disease and other infectious diseases issues; Ryan White reauthorization; Preservation of Antibiotics for Medical Treatment Act; Generating Antibiotic Incentives Now Act; Strategies to Address Antimicrobial Resistance (STAAR); PDUFA

Lobbyist	Covered position, as disclosed
ROBERT J GUIDOS	V.P. Public Policy & Government Relations
AMANDA JEZEK	Government Relations Director
KIMBERLY ANN MILLER	HIV Medicine Association Policy Officer

Contacted: Agency for Healthcare Research & Quality (AHRQ); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); U.S. Agency for International Development (USAID); SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH)

Medicare/Medicaid MMM

Reimbursement for outpatient infusion therapy; physician payments; Medicaid and Medicare, including Medicare Prescription Drug Coverage; Average Sales Price; Competitive Acquisition Program; infection control; antimicrobial stewardship; and Healthcare Reform.

Lobbyist	Covered position, as disclosed
ROBERT J GUIDOS	V.P. Public Policy & Government Relations
AMANDA JEZEK	Government Relations Director
KIMBERLY ANN MILLER	HIV Medicine Association Policy Officer

Contacted: Health Resources & Services Administration (HRSA); U.S. Agency for International Development (USAID); Agency for Healthcare Research & Quality (AHRQ); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Natl Institutes of Health (NIH)

Affiliated organisations

Organisation	Location
HIV MEDICINE ASSOCIATION	Arlington, VA, US

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.